Rochelle(Bagatell)Bagatell BergMD
Pediatric Hematology & Oncology • Philadelphia, PAPediatric Solid Tumor Oncology
Physician
Dr. Bagatell Berg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Chca Hematology & Oncology
Philadelphia, PA 19104Phone+1 215-590-2299Fax+1 215-590-3992
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 1996 - 1997
TMC Health Medical Education , Inc. (THMEP)Residency, Pediatrics, 1993 - 1996
University of Arizona College of MedicineClass of 1993
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 1998 - 2026
VA State Medical License 2022 - 2026
DE State Medical License 2022 - 2025
NC State Medical License 2022 - 2025
MD State Medical License 2022 - 2024
PA State Medical License 2008 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Publications & Presentations
PubMed
- 688 citationsNeuroblastoma.Christine Chung, Tom Boterberg, John Lucas, Joseph Panoff, Dominique Valteau-Couanet
Pediatric Blood & Cancer. 2021-05-01 - 95 citationsLong-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.Alice L. Yu, Andrew L. Gilman, M. Fevzi Ozkaynak, Arlene Naranjo, Mitchell B. Diccianni
Clinical Cancer Research. 2021-04-15 - 50 citationsPhase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory NeuroblastomaSteven G. DuBois, Yael P. Mosse, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid
Clinical Cancer Research. 2018-12-15
Press Mentions
NCCN Clinical Practice Guidelines in Oncology: 2024 UpdatesMay 20th, 2024
New Guidelines Say Risk Classification ‘Paramount’ in Treating Children with NeuroblastomaFebruary 12th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
